Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2011 (2011), Article ID 707126, 5 pages
http://dx.doi.org/10.1155/2011/707126
Clinical Study

The Serum Level of Fibroblast Growth Factor-23 and Calcium-Phosphate Homeostasis in Obese Perimenopausal Women

1Department of Internal Medicine and Metabolic Diseases, Medical University of Silesia, ul. Ziołowa 45/47, 40-635 Katowice, Poland
2Department of Pathophysiology, Medical University of Silesia, ul. Medyków 18, 40-752 Katowice, Poland
3Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, ul. Francuska 20-24, 40-027 Katowice, Poland

Received 25 July 2011; Revised 18 October 2011; Accepted 18 October 2011

Academic Editor: Vin Tangpricha

Copyright © 2011 M. Holecki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. A. Tremollieres, J. M. Pouilles, and C. Ribot, “Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women,” Journal of Clinical Endocrinology and Metabolism, vol. 77, no. 3, pp. 683–686, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. A. R. Glass, “Endocrine aspects of obesity,” Medical Clinics of North America, vol. 73, no. 1, pp. 139–160, 1989. View at Google Scholar · View at Scopus
  3. M. Holecki, B. Zahorska-Markiewicz, T. Nieszporek et al., “Selected parameters of bone turnover in obese perimenopausal women,” Annals Academy of Medicine, vol. 60, no. 2, pp. 186–191, 2006. View at Google Scholar
  4. M. Holecki, B. Zahorska-Markiewicz, T. Nieszporek et al., “Impact of the mass-reductive therapy with orlistat on 25-(OH)-D3 and PTH concentration in sera of obese, menopausal women,” Endokrynologia Polska, vol. 56, no. 3, pp. 240–245, 2005. View at Google Scholar · View at Scopus
  5. T. Andersen, P. McNair, N. Fogh-Andersen et al., “Increased parathyroid hormone as a consequence of changed complex binding of plasma calcium in morbid obesity,” Metabolism: Clinical and Experimental, vol. 35, no. 2, pp. 147–151, 1986. View at Google Scholar · View at Scopus
  6. L. Mosekilde, F. Melsen, I. Hessov et al., “Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity,” Gut, vol. 21, no. 7, pp. 624–631, 1980. View at Google Scholar · View at Scopus
  7. Z. Ostrowska, K. Zwirska-Korczala, B. Buntner, M. Pardela, and M. Drozdz, “Assessment of bone metabolism in obese women,” Endocrine Regulations, vol. 32, no. 4, pp. 177–181, 1998. View at Google Scholar · View at Scopus
  8. Y. Liel, E. Ulmer, J. Shary, B. W. Hollis, and N. H. Bell, “Low circulating vitamin D in obesity,” Calcified Tissue International, vol. 43, no. 4, pp. 199–201, 1988. View at Google Scholar · View at Scopus
  9. T. Yamashita, M. Yoshioka, and N. Itoh, “Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain,” Biochemical and Biophysical Research Communications, vol. 277, no. 2, pp. 494–498, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Mejhert, J. Galitzky, A. T. Pettersson et al., “Mapping of the fibroblast growth factors in human white adipose tissue,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 5, pp. 2451–2457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Liu, J. Zhou, W. Tang, X. Jiang, D. W. Rowe, and L. D. Quarles, “Pathogenic role of Fgf23 in Hyp mice,” American Journal of Physiology—Endocrinology and Metabolism, vol. 291, no. 1, pp. E38–E49, 2006. View at Publisher · View at Google Scholar
  12. J. Q. Feng, L. M. Ward, S. Liu et al., “Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism,” Nature Genetics, vol. 38, no. 11, pp. 1310–1315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Samadfam, C. Richard, L. Nguyen-Yamamoto, I. Bolivar, and D. Goltzman, “Bone formation regulates circulating concentrations of fibroblast growth factor 23,” Endocrinology, vol. 150, no. 11, pp. 4835–4845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Shimada, H. Hasegawa, Y. Yamazaki et al., “FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis,” Journal of Bone and Mineral Research, vol. 19, no. 3, pp. 429–435, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Mirza, J. Alsiö, A. Hammarstedt et al., “Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly 236 individuals,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 1, pp. 219–227, 2011. View at Google Scholar
  16. L. A. Stevens, M. A. Claybon, C. H. Schmid et al., “Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities,” Kidney International, vol. 150, no. 9, pp. 604–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Mirza, M. K. Karlsson, D. Mellström et al., “Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men,” Journal of Bone and Mineral Research, vol. 26, no. 4, pp. 857–864, 2011. View at Google Scholar
  18. X. Yu, Y. Sabbagh, S. I. Davis, M. B. Demay, and K. E. White, “Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations,” Bone, vol. 36, no. 6, pp. 971–977, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. D. M. Antoniucci, T. Yamashita, and A. A. Portale, “Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 8, pp. 3144–3149, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Kawata, Y. Imanishi, K. Kobayashi et al., “Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism,” Journal of the American Society of Nephrology, vol. 18, no. 10, pp. 2683–2688, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Krajisnik, P. Björklund, R. Marsell et al., “Fibroblast growth factor-23 regulates parathyroid hormone and 1α-hydroxylase expression in cultured bovine parathyroid cells,” Journal of Endocrinology, vol. 195, no. 1, pp. 125–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Z. Ben-Dov, H. Galitzer, V. Lavi-Moshayoff et al., “The parathyroid is a target organ for FGF23 in rats,” Journal of Clinical Investigation, vol. 117, no. 12, pp. 4003–4008, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. S. A. M. Burnett, S. C. Gunawardene, F. R. Bringhurst, H. Jüppner, H. Lee, and J. S. Finkelstein, “Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women,” Journal of Bone and Mineral Research, vol. 21, no. 8, pp. 1187–1196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. P. O'Donnell, B. L. Kasiske, M. P. Cleary, and W. F. Keane, “Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies,” The Journal of Laboratory and Clinical Medicine, vol. 106, no. 5, pp. 605–610, 1985. View at Google Scholar · View at Scopus
  25. B. L. Kasiske and J. Napier, “Glomerular sclerosis in patients with massive obesity,” American Journal of Nephrology, vol. 5, no. 1, pp. 45–50, 1985. View at Google Scholar · View at Scopus
  26. H. Wang, Y. Yoshiko, R. Yamamoto et al., “Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro,” Journal of Bone and Mineral Research, vol. 23, no. 6, pp. 939–948, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Holecki, B. Zahorska-Markiewicz, J. Chudek et al., “Changes in bone mineral density and markers of bone turnover in obese women after short weight loss treatment during five-year observation,” Polish Archives of Internal Medicine, vol. 120, no. 7-8, pp. 248–254, 2010. View at Google Scholar
  28. R. Marsell, M. A. I. Mirza, H. Mallmin et al., “Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men,” Osteoporosis International, vol. 20, no. 7, pp. 1167–1173, 2009. View at Publisher · View at Google Scholar · View at Scopus